Drug‐Drug Interaction between Itraconazole and the Antiretroviral Drug Lopinavir/Ritonavir in an HIV‐1–Infected Patient with Disseminated Histoplasmosis
Open Access
- 15 April 2004
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (8) , e73-e75
- https://doi.org/10.1086/382675
Abstract
We describe a drug-drug interaction between coformulated lopinavir/ritonavir and itraconazole in a patient infected with human immunodeficiency virusKeywords
This publication has 10 references indexed in Scilit:
- Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryJournal of Mass Spectrometry, 2003
- Lopinavir/RitonavirDrugs, 2003
- Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patientsJournal of Chromatography B, 2002
- Pharmacology of ItraconazoleDrugs, 2001
- Itraconazole and HIV protease inhibitors: an important interactionThe Medical Journal of Australia, 1999
- Optimisation of Itraconazole Therapy Using Target Drug ConcentrationsClinical Pharmacokinetics, 1998
- Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasisAntimicrobial Agents and Chemotherapy, 1997
- Itraconazole Maintenance Treatment for Histoplasmosis in AIDS: A Prospective, Multicenter TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndromeThe American Journal of Medicine, 1995